Respirent Pharmaceuticals Co
China - ChongqingPharmaceutical
Focus: Respirent Pharmaceuticals is a China-based respiratory medicines specialist founded in 2018, focused on generic and bioequivalent formulations of established respiratory treatments like fluticasone propionate and salmeterol combinations.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Respirent Pharmaceuticals Co
AI assessmentNot HiringNo open roles listed right now. Follow Respirent Pharmaceuticals Co to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Approved combination product targeting high-volume respiratory indications; represents core revenue base but faces generic competition and established market saturation.
Products & Portfolio (1)
Help build intelligence for Respirent Pharmaceuticals Co
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.